• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

米力农与肺血管系统。

Milrinone and the pulmonary vascular system.

作者信息

Harris M N, Daborn A K, O'Dwyer J P

机构信息

St Thomas' Hospital, London, United Kingdom.

出版信息

Eur J Anaesthesiol Suppl. 1992;5:27-30.

PMID:1600965
Abstract

In a multicentre study of 99 adult patients undergoing cardiac surgery, if post-operative cardiac failure was demonstrated (pulmonary capillary wedge pressure greater than 8 mmHg, cardiac index less than 2.5 litre min-1 m-2), then a bolus dose of milrinone (50 micrograms kg-1) was given, followed by an infusion at one of three rates (0.375, 0.5 or 0.75 microgram kg-1 min-1), and haemodynamic effects were assessed. Mean pulmonary artery pressures fell by 15% initially (P less than 0.001), and this significant reduction was maintained throughout the infusion period and reversed with the withdrawal of milrinone. Mean pulmonary vascular resistance fell progressively throughout the infusion period, the maximum change (30-40%) being evident at the 12 h point (P less than 0.05). Reversal of this effect after terminating the milrinone infusion was less marked than with pulmonary capillary wedge pressure or mean pulmonary artery pressure. A group of 39 of these patients from two centres were retrospectively divided into three groups: 1. Mitral valve replacement with high baseline pulmonary vascular resistance (greater than 200 dyne s cm-5) 2. Coronary revascularization with lower baseline pulmonary vascular resistance (100-200 dyne s cm-5) 3. Coronary revascularization with high baseline pulmonary vascular resistance (greater than 200 dyne s cm-5). There was a significant reduction in pulmonary vascular resistance and increase in cardiac index in all patients. At the 15 min point, there was significant between-group variation, the fall in pulmonary vascular resistance and increase in cardiac index being greater in Group 1 than in Groups 2 or 3. This difference between groups was not maintained during the infusion.

摘要

在一项针对99例接受心脏手术的成年患者的多中心研究中,如果术后出现心力衰竭(肺毛细血管楔压大于8 mmHg,心脏指数小于2.5升·分钟⁻¹·米⁻²),则给予负荷剂量的米力农(50微克·千克⁻¹),随后以三种速率之一(0.375、0.5或0.75微克·千克⁻¹·分钟⁻¹)进行输注,并评估血流动力学效应。平均肺动脉压最初下降了15%(P小于0.001),这种显著下降在整个输注期间持续存在,并在停用米力农后逆转。平均肺血管阻力在整个输注期间逐渐下降,最大变化(30 - 40%)在12小时时最为明显(P小于0.05)。停用米力农输注后,这种效应的逆转不如肺毛细血管楔压或平均肺动脉压明显。来自两个中心的39例患者被回顾性地分为三组:1. 基线肺血管阻力高(大于200达因·秒·厘米⁻⁵)的二尖瓣置换术;2. 基线肺血管阻力低(100 - 200达因·秒·厘米⁻⁵)的冠状动脉血运重建术;3. 基线肺血管阻力高(大于200达因·秒·厘米⁻⁵)的冠状动脉血运重建术。所有患者的肺血管阻力均显著降低,心脏指数均升高。在15分钟时,组间存在显著差异,第1组肺血管阻力的下降和心脏指数的升高大于第2组或第3组。在输注期间,各组之间的这种差异未持续存在。

相似文献

1
Milrinone and the pulmonary vascular system.米力农与肺血管系统。
Eur J Anaesthesiol Suppl. 1992;5:27-30.
2
Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension.大剂量米力农对重度左心室功能不全患者血流动力学变量及肺血管阻力的影响:一项肺动脉高压可逆性的快速检测
J Am Coll Cardiol. 1996 Dec;28(7):1775-80. doi: 10.1016/S0735-1097(96)00399-3.
3
Acute hemodynamic effects of intravenous sildenafil citrate in congestive heart failure: comparison of phosphodiesterase type-3 and -5 inhibition.静脉注射枸橼酸西地那非对充血性心力衰竭的急性血流动力学影响:磷酸二酯酶3型和5型抑制作用的比较
J Heart Lung Transplant. 2009 Jul;28(7):676-82. doi: 10.1016/j.healun.2009.04.013. Epub 2009 May 13.
4
Haemodynamic and biological effects of intravenous milrinone in patients with a low cardiac output syndrome following cardiac surgery: multicentre study.心脏手术后低心排血量综合征患者静脉应用米力农的血流动力学及生物学效应:多中心研究
Eur J Anaesthesiol Suppl. 1992;5:31-4.
5
Overview of the effects of intravenous milrinone in acute heart failure following surgery.静脉注射米力农对术后急性心力衰竭影响的概述
Eur J Anaesthesiol Suppl. 1992;5:35-41.
6
Milrinone in the treatment of low output states following cardiac surgery.米力农用于治疗心脏手术后低心排血量状态。
Eur J Anaesthesiol Suppl. 1992;5:21-6.
7
Intravenous milrinone following cardiac surgery: I. Effects of bolus infusion followed by variable dose maintenance infusion. The European Milrinone Multicentre Trial Group.心脏手术后静脉注射米力农:I. 推注后可变剂量维持输注的效果。欧洲米力农多中心试验组
J Cardiothorac Vasc Anesth. 1992 Oct;6(5):554-62. doi: 10.1016/1053-0770(92)90097-q.
8
A Canadian multicentre study of a 48 h infusion of milrinone in patients with severe heart failure.一项针对重度心力衰竭患者进行米力农48小时静脉输注的加拿大多中心研究。
Can J Cardiol. 1991 Jan-Feb;7(1):5-10.
9
Intravenous milrinone following cardiac surgery: II. Influence of baseline hemodynamics and patient factors on therapeutic response. The European Milrinone Multicentre Trial Group.心脏手术后静脉注射米力农:II. 基线血流动力学和患者因素对治疗反应的影响。欧洲米力农多中心试验组
J Cardiothorac Vasc Anesth. 1992 Oct;6(5):563-7. doi: 10.1016/1053-0770(92)90098-r.
10
Hemodynamic effects of i.v. milrinone lactate in pediatric patients with septic shock. A prospective, double-blinded, randomized, placebo-controlled, interventional study.静脉注射乳酸米力农对小儿感染性休克患者的血流动力学影响。一项前瞻性、双盲、随机、安慰剂对照的干预性研究。
Chest. 1996 May;109(5):1302-12. doi: 10.1378/chest.109.5.1302.

引用本文的文献

1
Inhaled nitric oxide as an independent intervention to lower the risk of bronchopulmonary dysplasia in preterm infants (< 33 weeks) with pulmonary hypertension within the initial 3 days of life.吸入一氧化氮作为一种独立干预措施,用于降低出生后最初3天内患有肺动脉高压的早产儿(<33周)发生支气管肺发育不良的风险。
Sci Rep. 2025 Jul 2;15(1):22517. doi: 10.1038/s41598-025-06055-0.
2
Pulmonary vascular and right ventricular dysfunction in adult critical care: current and emerging options for management: a systematic literature review.成人重症监护中的肺血管和右心室功能障碍:管理的当前和新兴选择:系统文献回顾。
Crit Care. 2010;14(5):R169. doi: 10.1186/cc9264. Epub 2010 Sep 21.
3
Effects of concomitant usage of milrinone and catecholamine for weaning from cardiopulmonary bypass.
米力农与儿茶酚胺联合用于体外循环撤机的效果
Jpn J Thorac Cardiovasc Surg. 1998 Sep;46(9):803-9. doi: 10.1007/BF03217826.
4
Clinical pharmacokinetics of vasodilators. Part II.血管扩张剂的临床药代动力学。第二部分。
Clin Pharmacokinet. 1998 Jul;35(1):9-36. doi: 10.2165/00003088-199835010-00002.
5
Cyclic nucleotide phosphodiesterases in the human lung.人类肺部中的环核苷酸磷酸二酯酶
Lung. 1994;172(3):129-46. doi: 10.1007/BF00175942.